(Report ID: 36028) Drug interactions analysis of:
Aromasin, Levothyroxine Sodium, HydrochlorothiazideMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,594 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 16 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 36028 | Jan, 27, 2006 | 73 | Female |
List of drugs the patient takes:
| Drug |
Aromasin |
Levothyroxine Sodium |
Hydrochlorothiazide |
| Name |
Amnesia |
Arthropathy |
Diplegia |
Electroencephalogram Abnormal |
Headache |
Hyperhidrosis |
Incoherent |
Transient Ischaemic Attack |
Results from eHealthMe: 16 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Amnesia | 2 (12.50%) |
Arthropathy | 1 (6.25%) |
Diplegia | 2 (12.50%) |
Electroencephalogram Abnormal | 2 (12.50%) |
Headache | 1 (6.25%) |
Hyperhidrosis | 1 (6.25%) |
Incoherent | 1 (6.25%) |
Transient Ischaemic Attack | 2 (12.50%) |
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Thyroid Disorder | 2 (100.00%) |
2 | Thinking Abnormal | 2 (100.00%) |
3 | Drug Withdrawal Syndrome | 2 (100.00%) |
4 | Depression | 2 (100.00%) |
5 | Convulsion | 2 (100.00%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Zoloft | 3 |
2 | Lipitor | 2 |
3 | Nexium | 2 |
4 | Lyrica | 2 |
5 | Levoxyl | 2 |
6 | Xanax | 2 |
7 | Hydrocodone | 1 |
8 | Potassium | 1 |
9 | Potassium Chloride | 1 |
10 | Hydrocodone Bitartrate | 1 |
Death: 0
Cancer: 1 (6.25% of total reports)
| Name | Count (% of total reports) |
1 | Depression | 5 (31.25%) |
2 | Thinking Abnormal | 4 (25.00%) |
3 | Insomnia | 3 (18.75%) |
4 | Hypertension | 3 (18.75%) |
5 | Weight Increased | 3 (18.75%) |
6 | Fatigue | 3 (18.75%) |
7 | Platelet Count Decreased | 3 (18.75%) |
8 | Myeloid Leukaemia | 3 (18.75%) |
9 | White Blood Cell Count Increased | 3 (18.75%) |
10 | Haemoglobin Decreased | 3 (18.75%) |
| Name | Count |
1 | Synthroid | 8 |
2 | Lipitor | 5 |
3 | Zoloft | 5 |
4 | Coumadin | 4 |
5 | Xanax | 4 |
6 | Fosamax | 3 |
7 | Nexium | 3 |
8 | Levoxyl | 3 |
9 | Ambien | 3 |
10 | Topamax | 3 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
